BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang L, Sun L, Liu R, Mo H, Niu Y, Chen T, Wang Y, Han S, Tu K, Liu Q. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression. J Exp Clin Cancer Res 2021;40:72. [PMID: 33596983 DOI: 10.1186/s13046-021-01868-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 25.0] [Reference Citation Analysis]
Number Citing Articles
1 Miao J, Gao Y, Guan W, Yu X, Wang Y, Jiang P, Yang L, Xu L, You W. High level of LncRNA MAPKAPK5-AS1 predicts poor prognosis and contributes to the malignant proliferation and EMT of non-small cell lung cancer via sponging miR-490-3p from HMGB2. Genes Genom 2022. [DOI: 10.1007/s13258-022-01339-5] [Reference Citation Analysis]
2 Li Z, Fang Y, Zhang Y, Zhou X. RNA-seq analysis of differentially expressed LncRNAs from leishmaniasis patients compared to uninfected humans. Acta Tropica 2022. [DOI: 10.1016/j.actatropica.2022.106738] [Reference Citation Analysis]
3 Su Y, Xie R, Xu Q. LncRNA THAP9-AS1 highly expressed in tissues of hepatocellular carcinoma and accelerates tumor cell proliferation. Clin Res Hepatol Gastroenterol 2022;:102025. [PMID: 36170961 DOI: 10.1016/j.clinre.2022.102025] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Zhu N, Chen X, Zhao J, Fang L, Yao Y, Zhou F, Tao L, Xu Q. Hypoxia-induced LINC00674 facilitates hepatocellular carcinoma progression by activating the NOX1/mTOR signaling pathway. J Cancer 2022;13:3177-88. [PMID: 36118523 DOI: 10.7150/jca.76458] [Reference Citation Analysis]
5 Lu Q, Wang H, Lei X, Ma Q, Zhao J, Sun W, Guo C, Huang D, Xu Q. LncRNA ALKBH3-AS1 enhances ALKBH3 mRNA stability to promote hepatocellular carcinoma cell proliferation and invasion. J Cell Mol Med 2022. [PMID: 36098205 DOI: 10.1111/jcmm.17558] [Reference Citation Analysis]
6 zeng X, Liu C, He Q, Zou Z, Liao Q, Wu C, Li G, Zhang Z, Tian Y, Zhu S, Yang X, Cui S, Zeng L. A novel lncRNA BF368575 promotes cell proliferation in hepatocellular carcinoma via PI3K/AKT/mTOR signaling pathway.. [DOI: 10.21203/rs.3.rs-2027515/v1] [Reference Citation Analysis]
7 Chen S, Liu R, Wang H, Liu Q. Hypoxia-driven miR-1307-3p promotes hepatocellular carcinoma cell proliferation and invasion by modulating DAB2 interacting protein. Pathol Res Pract 2022;237:154066. [PMID: 35985237 DOI: 10.1016/j.prp.2022.154066] [Reference Citation Analysis]
8 Wang Y, Setiawan MF, Liu H, Dakal TC, Liu H, Ge F, Rudan O, Chen P, Zhao C, Gonzalez-carmona MA, Kornek MT, Strassburg CP, Schmid M, Maciaczyk J, Sharma A, Schmidt-wolf IGH. Regulator of G Protein Signaling 20 Correlates with Long Intergenic Non-Coding RNA (lincRNAs) Harboring Oncogenic Potential and Is Markedly Upregulated in Hepatocellular Carcinoma. Biology 2022;11:1174. [DOI: 10.3390/biology11081174] [Reference Citation Analysis]
9 Wang D, Zhang L, Zhang Y, Zhang Y, Xu S. A ferroptosis-associated lncRNAs signature predicts the prognosis of hepatocellular carcinoma. Medicine (Baltimore) 2022;101:e29546. [PMID: 35839000 DOI: 10.1097/MD.0000000000029546] [Reference Citation Analysis]
10 Ma Y, Di Y, Li Q, Zhan Q, He X, Liu S, Zou H, Corpe C, Chen L, Wang J. LncRNAs as epigenetic regulators of epithelial to mesenchymal transition in pancreatic cancer. Discov Oncol 2022;13:61. [PMID: 35819532 DOI: 10.1007/s12672-022-00522-0] [Reference Citation Analysis]
11 Islam S, Mukherjee C. Molecular regulation of hypoxia through the lenses of noncoding RNAs and epitranscriptome. WIREs RNA 2022. [DOI: 10.1002/wrna.1750] [Reference Citation Analysis]
12 Shen G, Wang H, Zhu N, Lu Q, Liu J, Xu Q, Huang D. HIF-1/2α-Activated RNF146 Enhances the Proliferation and Glycolysis of Hepatocellular Carcinoma Cells via the PTEN/AKT/mTOR Pathway. Front Cell Dev Biol 2022;10:893888. [PMID: 35721496 DOI: 10.3389/fcell.2022.893888] [Reference Citation Analysis]
13 Dandapath I, Gupta R, Singh J, Shukla N, Jha P, Sharma V, Suri A, Sharma MC, Suri V, Sarkar C, Kulshreshtha R. Long Non-coding RNA and mRNA Co-expression Network Reveals Novel Players in Pleomorphic Xanthoastrocytoma. Mol Neurobiol 2022. [PMID: 35674862 DOI: 10.1007/s12035-022-02893-5] [Reference Citation Analysis]
14 Yan H, He N, He S. HCG15 is a hypoxia-responsive lncRNA and facilitates hepatocellular carcinoma cell proliferation and invasion by enhancing ZNF641 transcription. Biochemical and Biophysical Research Communications 2022;608:170-6. [DOI: 10.1016/j.bbrc.2022.03.143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhao Z, Fu C, Zhang Y, Zhang Y, Yang X, Fu A. Inhibitory effect of protonic bis(5-amino-1,10-phenanthroline) on proliferation of hepatocellular carcinoma and its molecular mechanism. Arabian Journal of Chemistry 2022. [DOI: 10.1016/j.arabjc.2022.103982] [Reference Citation Analysis]
16 Peng Z, Ouyang X, Wang Y, Fan Q. MAPKAPK5-AS1 drives the progression of hepatocellular carcinoma via regulating miR-429/ZEB1 axis. BMC Mol Cell Biol 2022;23:21. [PMID: 35468721 DOI: 10.1186/s12860-022-00420-x] [Reference Citation Analysis]
17 陈 超. The Research Progress of LncRNA MAPKAPK5-AS1 in Malignant Tumors and Other Diseases. ACM 2022;12:10241-10248. [DOI: 10.12677/acm.2022.12111477] [Reference Citation Analysis]
18 Chen T, Liu R, Niu Y, Mo H, Wang H, Lu Y, Wang L, Sun L, Wang Y, Tu K, Liu Q. HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway. Cell Death Dis 2021;12:1152. [PMID: 34903711 DOI: 10.1038/s41419-021-04449-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
19 Tomaszewska W, Kozłowska-Masłoń J, Baranowski D, Perkowska A, Szałkowska S, Kazimierczak U, Severino P, Lamperska K, Kolenda T. miR-154 Influences HNSCC Development and Progression through Regulation of the Epithelial-to-Mesenchymal Transition Process and Could Be Used as a Potential Biomarker. Biomedicines 2021;9:1894. [PMID: 34944712 DOI: 10.3390/biomedicines9121894] [Reference Citation Analysis]
20 Wan W, Liu G, Li X, Liu Y, Wang Y, Pan H, Hu J. MiR-191-5p alleviates microglial cell injury by targeting Map3k12 (mitogen-activated protein kinase kinase kinase 12) to inhibit the MAPK (mitogen-activated protein kinase) signaling pathway in Alzheimer's disease. Bioengineered 2021;12:12678-90. [PMID: 34818971 DOI: 10.1080/21655979.2021.2008638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Liu Y, Liu R, Zhao J, Zeng Z, Shi Z, Lu Q, Guo J, Li L, Yao Y, Liu X, Xu Q. LncRNA TMEM220-AS1 suppresses hepatocellular carcinoma cell proliferation and invasion by regulating the TMEM220/β-catenin axis. J Cancer 2021;12:6805-13. [PMID: 34659569 DOI: 10.7150/jca.63351] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Shi T, Morishita A, Kobara H, Masaki T. The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment. Int J Mol Sci 2021;22:10630. [PMID: 34638971 DOI: 10.3390/ijms221910630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Lu X, Tu H, Tang D, Huang X, Sun F. miR-130a-3p Enhances the Chemosensitivity of Y79 Retinoblastoma Cells to Vincristine by Targeting PAX6 Expression. Curr Eye Res 2021;:1-8. [PMID: 34547965 DOI: 10.1080/02713683.2021.1984537] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Hu S, Zhang J, Fang X, Guo G, Dai J, Sheng Z, Li D, Chen J, Zhang L, Liu C, Gao Y. Identification of microRNA hsa-miR-30c-5p as an inhibitory factor in the progression of hepatocellular carcinoma and investigation of its regulatory network via comprehensive analysis. Bioengineered 2021;12:7165-77. [PMID: 34503377 DOI: 10.1080/21655979.2021.1979439] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
25 Son SW, Yun BD, Song MG, Lee JK, Choi SY, Kuh HJ, Park JK. The Hypoxia-Long Noncoding RNA Interaction in Solid Cancers. Int J Mol Sci 2021;22:7261. [PMID: 34298879 DOI: 10.3390/ijms22147261] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
26 Wang J, Liu R, Wang Y, Mo H, Niu Y, Xu Q, Liu Q. Repression of the miR-627-5p by histone deacetylase 3 contributes to hypoxia-induced hepatocellular carcinoma progression. J Cancer 2021;12:5320-30. [PMID: 34335948 DOI: 10.7150/jca.58697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Liang J, Zhi Y, Deng W, Zhou W, Li X, Cai Z, Zhu Z, Zeng J, Wu W, Dong Y, Huang J, Zhang Y, Xu S, Feng Y, Ding F, Zhang J. Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma. PeerJ 2021;9:e11627. [PMID: 34178478 DOI: 10.7717/peerj.11627] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
28 Zeng Z, Shi Z, Liu Y, Zhao J, Lu Q, Guo J, Liu X, Huang D, Xu Q. HIF-1α-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression. Biochem Biophys Res Commun 2021;566:80-6. [PMID: 34118595 DOI: 10.1016/j.bbrc.2021.06.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
29 Feng Y, Hu X, Ma K, Zhang B, Sun C. Genome-Wide Screening Identifies Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma. Biomed Res Int 2021;2021:6640652. [PMID: 34095306 DOI: 10.1155/2021/6640652] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]